| Structure | Chemical Name | CAS | MF |
|
Carbamic acid, [3-[(3-chlorophenyl)methyl]-3,4-dihydro-4-oxo-2-propyl-6-quinazolinyl]-, 1,1-dimethylethyl ester (9CI)
|
579523-17-4
|
C23H26ClN3O3
|
|
Carbamic acid, [3-[(3-chlorophenyl)methyl]-3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl]-, 1,1-dimethylethyl ester (9CI)
|
579523-37-8
|
C21H22ClN3O3
|
|
Carbamic acid, [3-[(2-chlorophenyl)methyl]-3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl]-, 1,1-dimethylethyl ester (9CI)
|
579523-40-3
|
C21H22ClN3O3
|
|
Carbamic acid, [3-[(2-chlorophenyl)methyl]-3,4-dihydro-4-oxo-2-propyl-6-quinazolinyl]-, 1,1-dimethylethyl ester (9CI)
|
579523-64-1
|
C23H26ClN3O3
|
|
Carbamic acid, [3-([1,1-biphenyl]-4-ylmethyl)-3,4-dihydro-4-oxo-2-propyl-6-quinazolinyl]-, 1,1-dimethylethyl ester (9CI)
|
579523-65-2
|
C29H31N3O3
|
|
DL-2-Amino-3-(3-naphthalen-2-yl-phenyl)-propionic acid
|
579525-01-2
|
C19H17NO2
|
|
Methyl 2-(pyridin-4-yl)-1,3-benzoxazole-7-carboxylate
|
579525-07-8
|
C14H10N2O3
|
|
Ethyl 2-broMobenzo[d]thiazole-7-carboxylate
|
579525-09-0
|
C10H8BrNO2S
|
|
2-(Dimethylamino)pyridine-5-boronic acid hydrate
|
579525-46-5
|
C7H11BN2O2
|
|
3,5-Pyridinedicarbonitrile,2-methoxy-4,6-dimethyl-(9CI)
|
581055-04-1
|
C10H9N3O
|
|
Pyrazolo[3,4-b]azepine, 3-(2-benzofuranyl)-1-(2-fluorophenyl)-1,4,5,6,7,8-hexahydro- (9CI)
|
581056-85-1
|
C21H18FN3O
|
|
Benzonitrile, 2-[3-(2-benzofuranyl)-5,6,7,8-tetrahydropyrazolo[3,4-b]azepin-1(4H)-yl]- (9CI)
|
581059-57-6
|
C22H18N4O
|
|
tert-butyl 4-(mercaptomethyl)piperidine-1-carboxylate
|
581060-27-7
|
C11H21NO2S
|
|
2-amino-N-methoxy-N-methylacetamide hydrochloride
|
581063-34-5
|
C4H11ClN2O2
|
|
Stearoyl-NTA
|
581064-76-8
|
C28H52N2O7
|
|
1-(2-[3-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenoxy]-ethyl)-piperidine
|
581065-57-8
|
C19H30BNO3
|
|
(2-pyridyldithio)-PEG4 acid
|
581065-93-2
|
C16H25NO6S2
|
|
Tos-PEG5 t-butyl ester
|
581065-94-3
|
C22H36O9S
|
|
H2N-PEG4-tBu
|
581065-95-4
|
C15H31NO6
|
|
SPDP-PEG4-acid
|
581065-97-6
|
C19H30N2O7S2
|
|
N3-PEG4-tBu
|
581066-04-8
|
C15H29N3O6
|
|
Benzaldehyde, 2-fluoro-6-(trifluoromethyl)-, oxime
|
581072-15-3
|
C8H5F4NO
|
|
KJ Pyr 9
|
581073-80-5
|
C22H15N3O4
|
|
5'-O-Levulinoylthymidine 3'-CE phosphoramidite
|
581076-14-4
|
C24H37N4O8P
|
|
N-(4-Methyl-3-nitrophenyl)-4-(4-methylpiperazinomethyl)benzamide
|
581076-60-0
|
C20H24N4O3
|
|
N-(4-Methyl-3-aminophenyl)-4-(4-methylpiperazinomethyl)benzamide
|
581076-63-3
|
C20H26N4O
|
|
Imatinib Impurity 7
|
581076-64-4
|
C8H12N4
|
|
N-(3-Guanidino-4-methylphenyl)-4-(methylpiperazine-1-yl-methyl)benzamide
|
581076-65-5
|
C21H28N6O
|
|
Benzamide, 4-(dichloromethyl)-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-
|
581076-66-6
|
C24H19Cl2N5O
|
|
Imatinib USP Guanidine Analog
|
581076-67-7
|
C21H29ClN6O
|
|
N-Acetyl-S-(2,4-dimethylbenzene)-L-cysteine
|
581076-69-9
|
C13H17NO3S
|
|
N-Acetyl-S-(2,5-dimethylbenzene)-L-cysteine
|
581076-70-2
|
C13H17NO3S
|
|
N-Acetyl-S-(3,4-dimethylbenzene)-L-cysteine
|
581076-72-4
|
C13H17NO3S
|
|
Cyclopenta[4,5]pyrrolo[2,3-b]pyridine, 3-bromo-1,5,6,7-tetrahydro-
|
581083-15-0
|
C10H9BrN2
|
|
1H-Indazole-3-carboxylic acid, 4,5,6,7-tetrahydro-6,6-diMethyl-
|
581083-30-9
|
C10H14N2O2
|
|
Hydroxyethyl erucamidopropyl dimonium chloride
|
581089-19-2
|
C29H59ClN2O2
|
|
1,4-Benzenediol, 3,5-dimethoxy-2-(2-propenyl)- (9CI)
|
581092-38-8
|
C11H14O4
|
|
2-[3-[1,3-Dihydro-1,3-dimethyl-1-(phenylmethyl)-2H-benz[e]indol-2-ylidene]-1-propen-1-yl]-1,3-dimethyl-1-(phenylmethyl)-1H-benz[e]indolium hexafluorophosphate(1-) (1:1)
|
581092-53-7
|
C45H41N2+
|
|
Cyclopentanecarboxylic acid, 2,2,3-trimethyl-, (1S,3S)- (9CI)
|
581094-59-9
|
C9H16O2
|
|
1(2H)-Pentalenone,hexahydro-3a,6a-dimethyl-,(3aR,6aR)-(9CI)
|
581096-80-2
|
C10H16O
|
|
2(1H)-Pentalenone,hexahydro-3a,6a-dimethyl-4-(1-methylethenyl)-,(3aS,4S,6aS)-(9CI)
|
581096-88-0
|
C13H20O
|
|
p38 MAP Kinase Inhibitor III
|
581098-48-8
|
C23H21FN4S
|
|
Sodium 4-Hydroxy-4methylpentanoate
|
581099-89-0
|
C6H13NaO3
|
|
1-Butyl-3-ethylimidazolium tetrafluoroborate
|
581101-91-9
|
C9H17BF4N2
|
|
2,3-dihydro-2-oxo-5-benzoxazolecarboxaldehyde
|
581102-27-4
|
C8H5NO3
|
|
1H-imidazole, 1-(2-bromoethyl)-2-methyl-
|
581103-38-0
|
C6H10Br2N2
|
|
ethyl 2-(hydroxymethyl)-5,7-dimethyl-3-(2-(N-methylsulfamoyl)phenyl)-4-oxo-3,4-dihydroquinazoline-6-carboxylate
|
581106-13-0
|
C21H23N3O6S
|
|
3-Bromo-4-cyanobenzoic acid
|
581213-69-6
|
C8H4BrNO2
|
|
Atorvastatin Acetonide
|
581772-29-4
|
C36H39FN2O5
|
|
Cytidine, 2'-deoxy-2',5-difluoro-
|
581772-30-7
|
C9H11F2N3O4
|
|
Pyrazolo[3,4-b]azepine, 3-(2-benzofuranyl)-1-(3-bromophenyl)-1,4,5,6,7,8-hexahydro- (9CI)
|
581773-79-7
|
C21H18BrN3O
|
|
Benzoic acid, 3-[3-(2-benzofuranyl)-5,6,7,8-tetrahydropyrazolo[3,4-b]azepin-1(4H)-yl]- (9CI)
|
581774-93-8
|
C22H19N3O3
|
|
Ethyl (2E)-3-(4-bromo-2-fluorophenyl)prop-2-enoate
|
581778-88-3
|
C11H10BrFO2
|
|
4-cyano-5-[(cyanoacetyl)amino]-N,N-diethyl-3-methylthiophene-2-carboxamide
|
581780-63-4
|
C14H16N4O2S
|
|
3-Thiazolidinecarbothioamide,N-(4-chlorophenyl)-2-(4-methoxyphenyl)-(9CI)
|
581781-17-1
|
C17H17ClN2OS2
|
|
Benzoic acid, 4-[[[2-(4-methoxyphenyl)-3-thiazolidinyl]thioxomethyl]amino]-, ethyl ester (9CI)
|
581781-18-2
|
C20H22N2O3S2
|
|
Benzoic acid, 4-[[[2-(4-bromophenyl)-3-thiazolidinyl]thioxomethyl]amino]-, ethyl ester (9CI)
|
581781-19-3
|
C19H19BrN2O2S2
|
|
Benzoic acid, 4-[[[2-(2-thienyl)-3-thiazolidinyl]thioxomethyl]amino]-, ethyl ester (9CI)
|
581781-20-6
|
C17H18N2O2S3
|
|
N-{[(4-bromophenyl)amino]carbonothioyl}-2-(4-methoxyphenoxy)acetamide
|
581781-52-4
|
C16H15BrN2O3S
|
|
N-benzyl-4-{2-[3-(4-methoxyphenyl)acryloyl]hydrazino}-4-oxobutanamide
|
581781-64-8
|
C21H23N3O4
|
|
N,N'-1,2-ethanediylbis(N-phenylbenzenesulfonamide)
|
581781-92-2
|
C26H24N2O4S2
|
|
N-{4-[acetyl(methyl)amino]phenyl}-2-(1-naphthyl)acetamide
|
581781-99-9
|
C21H20N2O2
|
|
N-(4-bromo-3-chlorophenyl)-2-(1-naphthyl)acetamide
|
581782-00-5
|
C18H13BrClNO
|
|
N-(4-anilinophenyl)-3-bromo-4-tert-butylbenzamide
|
581782-04-9
|
C23H23BrN2O
|
|
Benzo[b]thiophene-2-carboxylic acid, 3-chloro-6-methoxy-, 2-(1-naphthalenylacetyl)hydrazide (9CI)
|
581782-11-8
|
C22H17ClN2O3S
|
|
2-cyano-N-(4-{[(4-methylpyrimidin-2-yl)amino]sulfonyl}phenyl)acetamide
|
581782-17-4
|
C14H13N5O3S
|
|
L-Alanine, L-alanyl-, ion(1-) (9CI)
|
581782-45-8
|
C6H11N2O3-
|
|
Octanoic acid, 1,1-diMethylpropyl ester
|
581784-60-3
|
C13H26O2
|
|
Norfunalenone
|
581786-63-2
|
C14H10O6
|
|
Phenol, 3,5-difluoro-4-mercapto- (9CI)
|
581793-28-4
|
C6H4F2OS
|
|
Phenol, 2,3-difluoro-4-mercapto- (9CI)
|
581793-29-5
|
C6H4F2OS
|
|
1-Cyclohexene-1-carboxaldehyde,2-(3-oxo-1-butynyl)-(9CI)
|
581794-04-9
|
C11H12O2
|
|
Butanoic acid, 2-(ethoxyhydroxymethylene)-, ethyl ester
|
581796-80-7
|
C9H16O4
|
|
Benzenepropanoic acid, a-[hydroxy(2-hydroxyethoxy)Methylene]-,2-hydroxyethyl ester
|
581796-84-1
|
C14H18O4
|
|
AG 490, m-CF3
|
581797-29-7
|
C18H13F3N2O3
|
|
erythro-Pentonic acid, 4,5-dideoxy-2-O-methyl-2-C-phenyl-, ba-lactone (9CI)
|
581799-70-4
|
C12H14O3
|
|
Benzenemethanol, 2-methoxy-alpha-methylene- (9CI)
|
581799-84-0
|
C9H10O2
|
|
Benzenemethanol, 4-ethyl-alpha-methylene- (9CI)
|
581799-86-2
|
C10H12O
|
|
2-broMo-trans-beta-styrylboronic acid pinacol ester
|
581802-24-6
|
C14H18BBrO2
|
|
3-nitro-trans-beta-styrylboronic acid pinacol ester
|
581802-25-7
|
C14H18BNO4
|
|
(E)-2-Methyl-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)but-3-en-2-ol
|
581802-26-8
|
C11H21BO3
|
|
Ketoconazole Impurity 1
|
581806-59-9
|
C12H14N2O2
|
|
2H-3,1-Benzoxazin-2-imine,octahydro-1-methyl-,(4aR,8aR)-rel-(9CI)
|
581806-90-8
|
C9H16N2O
|
|
Bixafen|
|
581809-46-3
|
C18H12Cl2F3N3O
|
|
1-(4-(Trifluoromethyl)benzyl)-3-(isoquinolin-5-yl)urea
|
581809-67-8
|
C18H14F3N3O
|
|
5-Isoquinolineacetic acid, ethyl ester
|
581811-80-5
|
C13H13NO2
|
|
Isoquinoline, 5-isocyanato- (9CI)
|
581812-66-0
|
C10H6N2O
|
|
[4-(thiomorpholin-4-yl)phenyl]methanamine
|
581812-68-2
|
C11H16N2S
|
|
Methyl 5-nitro-3-isoquinolinecarboxylate
|
581812-72-8
|
C11H8N2O4
|
|
4-Isocyanato-1H-indole
|
581812-74-0
|
C9H6N2O
|
|
1H-Indazole-1-carboxylicacid,4-amino-,methylester(9CI)
|
581812-76-2
|
C9H9N3O2
|
|
4-Azepan-1-yl-benzylamine
|
581812-79-5
|
C13H20N2
|
|
1-Cyclopropyl-1-(4-trifluoromethylphenyl)methylamine
|
581812-93-3
|
C11H12F3N
|
|
(4-bromo-3-fluorophenyl)methanamine
|
581812-99-9
|
C7H7BrFN
|
|
5-Isoquinolinamine,3-fluoro-(9CI)
|
581813-05-0
|
C9H7FN2
|
|
5-Isoquinolinamine,1,3-dimethyl-(9CI)
|
581813-08-3
|
C11H12N2
|
|
Cyclohexanemethanamine, 4-(1,1-dimethylethyl)-
|
581813-13-0
|
C11H23N
|
|
1-[3-Fluoro-4-(trifluoromethyl)phenyl]ethan-1-amine
|
581813-14-1
|
C9H9F4N
|
|
3-Bromo-4-(trifluoromethyl)benzoic acid
|
581813-17-4
|
C8H4BrF3O2
|
|
(3-broMo-4-(trifluoroMethyl)phenyl)MethanaMine
|
581813-19-6
|
C8H7BrF3N
|